COYA
NASDAQ
$4.44
Coya Therapeutics Inc (COYA)
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company is headquartered in Houston, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $15.21 (+242.57%)
Market Cap
$114M
Free Cash Flow Yield
-12.44%
Beta (5Y)
1.06
Price Chart
Valuation
Market Cap$114M
P/S14.30
P/B2.33
Profitability
Total Revenue (TTM)$7.94M
Gross Profit (TTM)-$7.68M
EBITDA-$22M
Profit Margin-266.1%
Operating Margin-3038%
EPS-$1.07
Financial Health
Free Cash Flow Yield-12.44%
Growth & Risk
Beta (5Y)1.06
Sharpe Ratio-0.17